1. Home
  2. SRPT vs DT Comparison

SRPT vs DT Comparison

Compare SRPT & DT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • DT
  • Stock Information
  • Founded
  • SRPT 1980
  • DT 2005
  • Country
  • SRPT United States
  • DT United States
  • Employees
  • SRPT N/A
  • DT N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • DT Computer Software: Prepackaged Software
  • Sector
  • SRPT Health Care
  • DT Technology
  • Exchange
  • SRPT Nasdaq
  • DT Nasdaq
  • Market Cap
  • SRPT 12.2B
  • DT 13.2B
  • IPO Year
  • SRPT 1997
  • DT 2019
  • Fundamental
  • Price
  • SRPT $120.39
  • DT $53.57
  • Analyst Decision
  • SRPT Buy
  • DT Buy
  • Analyst Count
  • SRPT 21
  • DT 25
  • Target Price
  • SRPT $179.38
  • DT $61.04
  • AVG Volume (30 Days)
  • SRPT 1.0M
  • DT 3.5M
  • Earning Date
  • SRPT 11-06-2024
  • DT 02-06-2025
  • Dividend Yield
  • SRPT N/A
  • DT N/A
  • EPS Growth
  • SRPT N/A
  • DT N/A
  • EPS
  • SRPT 1.22
  • DT 0.54
  • Revenue
  • SRPT $1,640,348,000.00
  • DT $1,563,293,000.00
  • Revenue This Year
  • SRPT $50.40
  • DT $20.44
  • Revenue Next Year
  • SRPT $71.44
  • DT $15.55
  • P/E Ratio
  • SRPT $103.94
  • DT $102.80
  • Revenue Growth
  • SRPT 48.45
  • DT 20.58
  • 52 Week Low
  • SRPT $89.92
  • DT $39.42
  • 52 Week High
  • SRPT $173.25
  • DT $61.41
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 50.01
  • DT 50.02
  • Support Level
  • SRPT $122.12
  • DT $53.82
  • Resistance Level
  • SRPT $128.73
  • DT $59.80
  • Average True Range (ATR)
  • SRPT 3.87
  • DT 1.40
  • MACD
  • SRPT -0.15
  • DT -0.30
  • Stochastic Oscillator
  • SRPT 11.14
  • DT 28.09

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.

About DT Dynatrace Inc.

Dynatrace is a cloud-native company that focuses on analyzing machine data. Its product portfolio, delivered as software as a service, allows a client to monitor and analyze its entire IT infrastructure. Dynatrace's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to use it for a variety of applications throughout their businesses.

Share on Social Networks: